National Health Investors (NYSE:NHI – Get Free Report) had its target price hoisted by analysts at Truist Financial from $76.00 to $77.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s target price would suggest a potential upside of 7.31% from the company’s previous close.
Separately, Wedbush reiterated an “outperform” rating and set a $88.00 price objective on shares of National Health Investors in a research note on Monday, March 17th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, National Health Investors currently has a consensus rating of “Hold” and an average price target of $85.75.
View Our Latest Analysis on National Health Investors
National Health Investors Price Performance
Shares of National Health Investors stock traded down $0.76 on Monday, hitting $71.75. The company’s stock had a trading volume of 302,816 shares, compared to its average volume of 238,122. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. National Health Investors has a 1 year low of $64.00 and a 1 year high of $86.13. The firm has a fifty day moving average price of $73.69 and a 200-day moving average price of $72.05. The company has a market capitalization of $3.35 billion, a price-to-earnings ratio of 24.66, a price-to-earnings-growth ratio of 4.42 and a beta of 0.75.
National Health Investors (NYSE:NHI – Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.13 by $0.02. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm had revenue of $68.87 million during the quarter, compared to analyst estimates of $85.13 million. During the same quarter in the previous year, the business earned $1.10 EPS. National Health Investors’s revenue for the quarter was up 9.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that National Health Investors will post 4.41 earnings per share for the current fiscal year.
Institutional Investors Weigh In On National Health Investors
Several large investors have recently bought and sold shares of NHI. Norges Bank purchased a new stake in National Health Investors during the 4th quarter worth approximately $42,322,000. Millennium Management LLC grew its position in shares of National Health Investors by 1,967.0% in the fourth quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust’s stock valued at $33,843,000 after purchasing an additional 464,727 shares in the last quarter. Balyasny Asset Management L.P. purchased a new stake in shares of National Health Investors in the fourth quarter valued at approximately $23,917,000. Marshall Wace LLP increased its holdings in shares of National Health Investors by 161.6% in the fourth quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust’s stock valued at $38,225,000 after purchasing an additional 340,712 shares during the last quarter. Finally, Land & Buildings Investment Management LLC lifted its position in National Health Investors by 109.4% during the fourth quarter. Land & Buildings Investment Management LLC now owns 467,056 shares of the real estate investment trust’s stock worth $32,367,000 after buying an additional 243,999 shares in the last quarter. 62.51% of the stock is currently owned by hedge funds and other institutional investors.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
See Also
Before you consider National Health Investors, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and National Health Investors wasn’t on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Source: marketbeat.com
